Salbutamol Completed Phase 2 Trials for Chronic Obstructive Pulmonary Disease (COPD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02182674A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00358488Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients
NCT02573870Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease
NCT02542254The Effects of RPL554 on Top of Standard COPD Reliever Medications